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SUMMARY 
Eighteen physically healthy volunteers were given 1200 mg of standard and sustained-release 
preparations of lithium on two different occasions. Serum lithium levels were estimated at four hourly intervals 
and statistically analysed. The findings and the results have been discussed with particular reference to their 
implications for future research. 
Lithium is an effective drug in the 
prophylaxis of manic depressive psychosis 
(Hullin et al., 1972). For its prophylactic 
effect, it should be taken regularly and 
serum lithium should remain within thera-
peutic range (Fieve, 1976). The con-
ventional lithium carbonate preparations 
are usually given in three or four divided 
doses daily (Cooper et al., 1978). However, 
it is clearly established that a patient is 
more likely to forget to take a dose in several 
times a day regimen than in once a day 
regimen (Ayd, 1974) ; hence a sustained 
release preparation which is taken once a 
day may have distinct advantage over the 
conventional preparations. The studies con-
ducted in various countries with such pre-
parations have shown that they are not 
sustained release preparations but only slow 
release preparations (Goppen et al., 1969 ; 
Persson, 1974 ; Crammer et al., 1974 ; 
Fyro et al., 1970 ; Amdisen, 1975 ; Tyrer 
et al. 1976 & Marini & Sheard, 1976). 
It has been reported on the one hand that 
at least three such slow release preparations 
(Camcolit, Norgine, Limited, Britain ; 
Priadel, Delandale Laboratories, Britain j 
Phasel, Pharmax Limited, Britain) show slow 
release only in vitro and not in vivo ; there 
is no difference between the rate of absorp-
tion and excretion of these three slow release 
preparations and conventional preparations, 
and at least one of these preparations 
(Phasal) is very poorly absorbed (Tyrer et 
al.. 1976). On the other hand, another 
slow-release preparation (Rowell Labora-
tories, Inc., Bandette, Minn., U.S.A.) has 
been reported to produce less post dose 
lithium level variability as compared to a 
standard release preparation (Cooper et 
al., 1978). Similarly lower and less steep 
serum lithium peaks have been reported 
with a plastic matrix type of slow release 
preparation than those occurring with con-
ventional tablets (Amdisen, 1969). Such 
seemingly conflicting reports from foreign 
studies and the fact that no study with slow 
release lithium preparation has been con-
ducted in India, motivated us to undertake 
this study. 
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AIM 
To compare the serum lithium levels 
produced by single dose of standard release 
lithium carbonate preparation (Licab, Tor-
rent Laboratory, Ahmedabad, India) & slow 
release lithium carbonate preparation 
(Priadel, Delandale Laboratories, U. K.) 
MATERIALS AND METHOD 
The sample of the present study con-
sisted of eighteen volunteers who were 
physically normal on a detailed clinical 
examination. Their base-line hc.emato-
logical investigations (Haemoglobin%, total 
& differential leukocyte counts & general 
blood picture) uiine examination, blood 
urea, serum creatinine & serum electro-
lytes also were within normal limits. 
Throughout the period of the study (8 
days) they were kept in the hospital on a 
standard hospital diet containing not less 
than 6 gm/day of sodium chloride and 
adequate water intake was ensured. The 
timings of distribution of breakfast, lunch 
& dinner were the same for each so as to 
neutralize any interference with absorption 
of the lithium tablets due to presence of 
food in gastro-intestinal tract which is known 
to produce wide changes in serum lithium 
levels (Amdisen, 1969). In the first phase 
of the study, all the volunteers were given 
1200 mg of slow release lithium carbonate 
preparation in a single dose with 500 cc 
of water, one hour after the morning meal. 
The blood samples were drawn at four 
hourly intervals for the next twenty-four 
hours. All the volunteers were closely 
watched for development of any sign of 
lithium toxicity. 
In the second phase of the study, con-
ducted six days after the first phase of study, 
the same volunteers with similar timings, 
schedule and precautions were given 1200 
mg of standard release (conventional) 
lithium carbonate preparation in single 
dose and blood samples were drawn in a 
similar manner. 
The serum lithium level was estimated 
by flame photometry which is an easy, 
rapid and sensitive method (Amdisen, 1967) 
and the results were compared. 
Observations: 
No signs of lithium toxicity were 
observed in any of the volunteers. 
The data collected revealed that— 
(1) If 0.6 to 1.5 mEq/lt. is taken as 
range of therapeutic serum lithium 
level, the number of toxic, thera-
peutic and sub-therapeutic sreum 
lithium values in relation to slow-
release and conventional lithium pre-
parations were 23 (21.3%) & 63 
(58.3%) ; 22 (20.4%) & 0 (0%), 
102 (9 4.4%) & 6 (5.6%) respec-
tively. The time of peak value 
ranged from 4 to 24 hrs. 
(2) 7 volunteers had a serum lithium 
level of 0 mEq/lt. after 12 hours 
of intake of long acting lithium. 
None of the volunteers revealed 
serum lithium level of 0 m 
Eq/lt. while taking short acting 
lithium. 
Table 1 shows the comparative sta-
tistical analysis of the serum lithium values 
with slow release and conventional lithium 
preparations. The mean serum lithium 
levels were consistently higher after intake 
of slow release lithium preparation than 
after intake of conventional lithium prepar-
ation except after twelve hours of intake 
when this relationship was reversed. 
Standard deviations were consistently higher 
for slow-release lithium preparation. There 
was a statistically significantly difference 
in corresponding serum lithium levels ob-
tained with slow-release & conventional 
lithium after 4 hrs. (p<.01) 12 hrs. (p<.001) 
20 hrs. (p<.001) & 24 hrs. (p<.05) after 
intake. There was no statistically significant 
correlation in corresponding serum lithium 
values obtained with slow release & con-
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TABLE 1—Comparative Statistical Analysis of the Serum Lithium Values 
Sets of Comparison  Mean  Standard Deviation 
Values of 
Values oft' correlation 
coefficient 
(r) 
Serum lithium values with long & 
short acting lithium after four 
hours 1.283 & 0.894 
Serum lithium values with long & 
short acting lithium after 8 hours 1.056 & 1.017 
Serum lithium values with long & 
short acting lithium after 12 hours 0.239 & 0.867 
Serum lithium values with long and 
short acting lithium after 16 hours 0.972 & 0.889 
Serum lithium values with long & 
short acting lithium after 20 hours 1.339 & 0.956 
Serum lithium values with long & 
short acting lithium after 24 hours 1.017 & 0.800 
0.508 & 0.346 3.07** 0.296 
0.464 & 0.345 0.49  0.253 
0.283 & 0.274  6.42*** 0.429 
0.375 & 0.197 1.16  0.059 
0.469 & 0.206  3.88*** 0.450 
0.338 & 0.171 2.60* 0.268 
*p< .05 **P<.01 ***p<.001 
TABLE 2—Comparison of Mean Serum Lithium Level Variations 
Sets of Comparison 
Mean 
Long acting Short Acting Value of 
Lithium Lithium 't' 
Difference between serum lithium values after 4 and 8 hours 0.2389 
Difference between serum lithium values after 4 and 12 hours 1.04 
Difference betseen serum lithium values after 4 and 16 hours 0.3400 
Difference between serum lithium values after 4 and 20 hours —0.055 
Difference between serum lithium values after 4 and 24 hours —0.2556 
—.0.1222 
0.00 
0.06111 
-0.06 
0.3297 
2.156* 
8.487*** 
2.97** 
0.060 
1.065 
*p<.05, **p<.01, ***p<.00l 
efficient of skewness (not shown in Table 
1) was computed to find out the normality 
of distribution of serum lithium values and 
it was found to be positively skewed in 
relation to both the preparations. The 
coefficient of kurtosis (not shown in Table 
1) revealed that the magnitude of serum 
lithium values in the positively skewed 
distribution curve did not follow any con-
sistent pattern in relation to any of the 
two preparations. 
Table 2 shows the comparisons of mean 
serum lithium level variations for long 
and short acting lithium preparations as 
calculated from the mean difference between 
4 hour serum lithium level (taken as base-
line lithium level) and the subsequent serum 
lithium levels. Such differences were sig-
nificantly more on the higher side with long 
acting lithium in 4 Vs. 8 hrs (p<.05), 
4 vs. 12 hrs. (p<.001) & 4 vs. 16 hrs. 
(p<.01) sets of values. 172  RAVI S. PANDEY et al. 
RESULTS AND DISCUSSION 
Absence of any side effects contradicts 
the reports of some previous studies (Persson, 
1974 ; Persson, 1971 ; Fyro et al., 1970) 
where diarrhoea was commonly reported 
only with slow-release preparations. 
Majority of the serum lithium values 
(94.4%) with single dose of short acting 
lithium preparation were within therapeutic 
range whereas only 58.3% of serum lithium 
values with long acting lithium preparations 
were within therapeutic ranges. This find-
ing very highly suggests that it is possible 
to administer short acting lithium prepara-
tion only once a day for therapeutic pur-
poses. The chances of toxic serum lithium 
levels are 0% & those of subtherapeutic 
levels are minimal (5.6%). It appears 
that conventional lithium preparation is 
superior to slow acting lithium (when both 
are given as once a day schedule) in main-
taining therapeutic blood levels and is also 
less likely to produce very high or very low 
levels. This finding sharply contrasts with 
that of another study (Tyrer et al., 1976) 
where a single dose of the same slow release 
preparation (Priadel) produced therapeutic 
levels in all the eight subjects at the height 
of peak ; mostly sub therapeutic levels after 
12 and 24 hours and toxic levels in none. 
It is difficult to explain such a vast differ-
ence completely but the following factors 
may be partly responsible for it— 
(A) Lesser dose of drug given (1000 
mg in Tyrer et al.'s study compared 
to 1200 mg in present study). 
(B) Relationship of lithium intake to 
time of food intake (fasting stomach 
in Tyrer et al.'s study compared to 
after breakfast in present study). 
It is known that conventional lithium 
preparations given with meals can 
produce almost double serum lithium 
levels of those obtained in early 
mornings without meals (Amdisen, 
1969). 
Absence of lithium in serum in 7 
volunteers after 12 hours shows that there 
may be some factor (disintegration of 
tablet, erratic absorption etc.) which ope-
rates only with long acting preparation 
whereby sometimes isolated, unpredictable 
and abnormally low serum lithium values 
may be obtained. As in this study, with 
single dose of Priadel, Coppen et al. (1969) 
also found widely varying times of peak 
values ranging from 3 to 24 hours. 
The standard deviations of serum 
lithium values with slow release prepara-
tion were consistently higher than those 
with conventional lithium preparation, sug-
gesting that the variations in serum lithium 
levels are more with slow release prepara-
tion than with the conventional one. With 
the same preparation (Priadel) Coppen 
et al. (1969) have reported similar findings. 
Amdisen (1969) found lesser variability 
and lower serum values with slow-release 
lithium preparation than with conven-
tional lithium preparation but his findings 
cannot be compared with those of this 
study because he had given both slow & 
standard release preparations in three 
divided doses in a day & had used another 
type of slow-release preparation (Plastic 
Matrix type). The mean serum lithium 
levels were usually (3 out of 4 significant 
values) significantly higher with slow-release 
preparation than with conventional pre-
paration. It suggests that relatively lower 
doses of slow release lithium than con-
ventional lithium may be required for 
therapeutic purposes (however, it will also 
greatly enhance the chances of sub thera-
peutic levels which were found in as high 
as in 20.4% of total observations in this 
study. Cooper et al. (1978) also found 
that slow release and conventional lithium 
preparations given in single dose were 
not bioequivalent. 
There was no significant correlation 
between the corresponding serum lithium 
values with slow and standard release pre-
parations suggesting that those who have SERUM LITHIUM LEVELS WITH SLOW-RELEASE AND CON. LITHIUM CARBONATE 173 
"experience" with the use of conventional 
lithium preparations cannot readily apply 
their experience to slow-release prepara-
tions. 
Since the coefficient of kurtosis did 
not follow any consistent pattern in case 
of either of the two preparations and the 
mean serum lithium level variations were 
consistently higher in all the five sets of 
values with slow-release preparation (and 
significantly so in three sets of values), it 
can be inferred that unpredictable high 
serum lithium level will be much likely to 
occur with slow-release preparation than 
with conventional lithium preparation. 
In view of the findings of the present 
study, it will be desirable to be cautious in 
using slow release forms of lithium until 
such times that further studies undertaken 
on larger samples prove its advantage over 
conventional preparations. 
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